Greg Renza

Stock Analyst at RBC Capital

(2.73)
# 1,937
Out of 4,876 analysts
1
Total ratings
100%
Success rate
20.73%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Greg Renza

BeOne Medicines
Apr 7, 2025
Initiates: Outperform
Price Target: $312
Current: $241.20
Upside: +29.35%